BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21319060)

  • 1. A survey of head and neck malignancy at Tokai University Hospital.
    Okami K; Hamano T; Takeo T; Sugimoto R; Sekine M; Iida M
    Tokai J Exp Clin Med; 2007 Jul; 32(2):62-6. PubMed ID: 21319060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of malignancies in head and neck regions and their management.
    Baskota DK; Agrawal R; Prasad R; Sinha BK
    JNMA J Nepal Med Assoc; 2005; 44(159):68-72. PubMed ID: 16554857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of head and neck cancers among Nigerians in Lagos.
    Nwawolo CC; Ajekigbe AT; Oyeneyin JO; Nwankwo KC; Okeowo PA
    West Afr J Med; 2001; 20(2):111-6. PubMed ID: 11768008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality of life in patients treated for cancer of paranasal sinus and other area at head and neck].
    Strek P; Oleś K; Składzień J; Tomik J; Gajec S; Kocoń S; Dutsch-Wicherek M; Hartwich P; Szaleniec J
    Przegl Lek; 2010; 67(12):1298-301. PubMed ID: 21591356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic management of upper esophageal strictures after treatment of head and neck malignancy.
    Ahlawat SK; Al-Kawas FH
    Gastrointest Endosc; 2008 Jul; 68(1):19-24. PubMed ID: 18355822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of head and neck cancer patients referred to an oral and maxillofacial surgeon in the United States for management.
    Holmes JD; Martin RA; Gutta R
    J Oral Maxillofac Surg; 2010 Mar; 68(3):555-61. PubMed ID: 20171475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country.
    Vartanian JG; Carvalho AL; Yueh B; Priante AV; de Melo RL; Correia LM; Köhler HF; Toyota J; Kowalski IS; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1209-13. PubMed ID: 15492171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Cancer Database report on cancer of the head and neck: 10-year update.
    Cooper JS; Porter K; Mallin K; Hoffman HT; Weber RS; Ang KK; Gay EG; Langer CJ
    Head Neck; 2009 Jun; 31(6):748-58. PubMed ID: 19189340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant mucosal melanomas of the head and neck--collective review from six cancer hospitals].
    Omura K; Takemiya S; Shimada F; Shimada A; Ono I; Uchida M; Tanigawa Y; Matsuura S; Takeoda K
    Gan No Rinsho; 1986 Oct; 32(12):1511-8. PubMed ID: 3783975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.
    Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
    Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 71 cases of multiple primary cancers in head and neck squamous carcinomas].
    Zhou YQ; Li XM; Gao CM; Zhao QL; Li GS; Cheng JM; Shang YD
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):232-6. PubMed ID: 15283285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FNA based diagnosis of head and neck nodal lymphoma.
    Kuvezdić KG; Aurer I; Ries S; Sucić M; Glamocak MM; Ilić I; Basić-Kinda S; Radman I; Labar B
    Coll Antropol; 2010 Mar; 34(1):7-12. PubMed ID: 20437634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.